Prothena Corp Files Proxy Materials
Ticker: PRTA · Form: DEFA14A · Filed: Mar 28, 2025 · CIK: 1559053
| Field | Detail |
|---|---|
| Company | Prothena Corp Public Ltd Co (PRTA) |
| Form Type | DEFA14A |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, sec-filing
TL;DR
Prothena filed proxy docs, no fee. All good.
AI Summary
Prothena Corporation plc filed a Definitive Additional Materials proxy statement on March 28, 2025. This filing is related to the company's proxy materials and does not involve a fee. Prothena Corporation plc is a pharmaceutical preparations company incorporated in L2 with its fiscal year ending on December 31.
Why It Matters
This filing indicates that Prothena Corporation plc is providing additional proxy materials to shareholders, which may contain important updates or information relevant to upcoming shareholder votes or meetings.
Risk Assessment
Risk Level: low — This filing is a routine proxy statement and does not contain information that inherently increases risk for investors.
Key Players & Entities
- PROTHENA CORP PUBLIC LTD CO (company) — Registrant
- Prothena Corporation plc (company) — Registrant (alternative name)
- 0001140361-25-011006 (filing_id) — Accession Number
- 20250328 (date) — Filing Date
FAQ
What type of filing is this?
This is a Definitive Additional Materials proxy statement (DEFA14A).
Who is the filing company?
The filing company is PROTHENA CORP PUBLIC LTD CO.
When was this filing made?
The filing was made on March 28, 2025.
Is there a fee associated with this filing?
No fee is required for this filing.
What is Prothena Corporation plc's industry?
Prothena Corporation plc is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on March 28, 2025 regarding PROTHENA CORP PUBLIC LTD CO (PRTA).